Research indicates β-blockers may reduce the risk of motor diagnosis and slow symptom progression in Huntington's disease, ...

Dr. Jamal Lewis’s lab is trying to repurpose a fungus to shuttle pharmaceuticals to the central nervous system and treat ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Title: Randomized, Double-Blind Study of BNC210, a Negative Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor, in Posttraumatic Stress Disorder (PTSD): The Attune Trial Presenter: Murray ...

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

Praxis management will be participating in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference, taking place in New York, NY at the Lotte New York Palace Hotel on December 4, 2024 ...

We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...

The complexity of the central nervous system (CNS) and its pathologies necessitates an intricate understanding of the cellular and molecular mechanisms at play. Single-cell biology has emerged as a ...

The autonomic nervous system orchestrates the functions of internal organs such as the heart and gut, serving as a connection ...

Astrocytes — named for their star-like shape — are a type of brain cell as abundant as neurons in the central nervous system, but little is known about their role in brain health and disease. Many ...